母亲患癌所生子女不良出生结局:一项基于人群的队列研究
基于983,162例妊娠数据,识别16,475例母亲癌症史,其中妊娠相关癌症2583例(6.75%)。妊娠相关癌症发生率为2.63/1000妊娠(95%CI 2.53‰-2.73‰)。孕中晚期诊断癌症与早产和低出生体重风险升高相关,孕早期诊断与出生缺陷风险升高相关(aRR 1.48,95%CI 1.08-2.04)。甲状腺癌幸存者早产、低出生体重和出生缺陷风险均升高。
要点
- 妊娠相关癌症发生率为2.63/1000妊娠,甲状腺癌最常见(1.15‰)。
- 孕中晚期诊断癌症与早产和低出生体重风险升高显著相关。
- 甲状腺癌幸存者早产、低出生体重和出生缺陷风险均升高。
核心结论
- 孕中晚期诊断癌症者应仔细监测胎儿生长以确保适时分娩并平衡新生儿健康与癌症治疗。
- 甲状腺癌幸存者不良出生结局风险升高,提示孕前及孕期定期监测甲状腺功能和调节甲状腺激素水平对维持妊娠和促进胎儿发育重要。
研究设计与样本
- 基于健康信息网络的基于人群的队列研究,共983,162例妊娠,识别16,475例有母亲癌症史(包括孕前癌症、妊娠相关癌症和后续癌症)。
- 采用泊松分布计算妊娠相关癌症发病率及95%置信区间,采用多水平对数二项模型估计不良出生结局与母亲癌症关联的调整风险比及95%置信区间。
主要发现
- 38,295例子代出生于有癌症史的母亲,其中2583例(6.75%)暴露于妊娠相关癌症,30,706例(80.18%)为后续癌症诊断,5006例(13.07%)暴露于孕前癌症。
- 妊娠相关癌症发生率为2.63/1000妊娠(95%CI 2.53‰-2.73‰),甲状腺癌(1.15‰)、乳腺癌(0.25‰)和女性生殖器官癌(0.23‰)为最常见类型。
- 孕中晚期诊断癌症与早产和低出生体重风险升高显著相关。
- 孕早期诊断癌症与出生缺陷风险升高相关(aRR 1.48,95%CI 1.08-2.04)。
- 甲状腺癌幸存者早产(aRR 1.16,95%CI 1.02-1.32)、低出生体重(aRR 1.24,95%CI 1.07-1.44)和出生缺陷(aRR 1.22,95%CI 1.10-1.35)风险升高。
临床怎么用
- 作者认为,孕中晚期诊断癌症的孕妇应仔细监测胎儿生长以确保适时分娩并平衡新生儿健康与癌症治疗。
- 作者认为,甲状腺癌幸存者孕前及孕期定期监测甲状腺功能和调节甲状腺激素水平对维持妊娠和促进胎儿发育重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With increasing cancer incidence and survival rates, the prevalence of maternal cancer and its effect on adverse birth outcomes are important for prenatal care and oncology management. However, the effects of different types of cancer at different gestational stages have not been widely reported. OBJECTIVE: This study aimed to describe the epidemiologic characteristics of pregnancy-associated cancers (during and 1 year after pregnancy) and evaluate the association between adverse birth outcomes and maternal cancers. METHODS: Of 983,162 cases, a history of maternal cancer, including pregestational cancer, pregnancy-associated cancer, and subsequent cancer, was identified in 16,475 cases using a health information network. The incidence and 95% confidence interval of pregnancy-associated cancer were calculated with the Poisson distribution. The adjusted risk ratio with 95% confidence interval of the association between adverse birth outcomes and maternal cancer were estimated using the multilevel log-binomial model. RESULTS: A total of 38,295 offspring were born to mothers with a cancer history. Of these, 2583 (6.75%) were exposed to pregnancy-associated cancer, 30,706 (80.18%) had a subsequent cancer diagnosis, and 5006 (13.07%) were exposed to pregestational cancer. The incidence of pregnancy-associated cancer was 2.63 per 1000 pregnancies (95% confidence interval, 2.53‰-2.73‰), with cancer of the thyroid (1.15‰), breast (0.25‰), and female reproductive organs (0.23‰) being the most common cancer types. The increased risks of preterm birth and low birthweight were significantly associated with cancer diagnosed during the second and third trimester of pregnancy, whereas increased risks of birth defects (adjusted risk ratio, 1.48; 95% confidence interval, 1.08-2.04) were associated with cancer diagnosed in the first trimester. Increased risks of preterm birth (adjusted risk ratio, 1.16; 95% confidence interval, 1.02-1.32), low birthweight (adjusted risk ratio, 1.24; 95% confidence interval, 1.07-1.44), and birth defects (adjusted risk ratio, 1.22; 95% confidence interval, 1.10-1.35) were observed in thyroid cancer survivors. CONCLUSION: Careful monitoring of fetal growth should be implemented for women diagnosed with cancer in the second and third trimester to ensure timely delivery and balance the benefits of neonatal health and cancer treatment. The higher incidence of thyroid cancer and increased risk of adverse birth outcomes among thyroid cancer survivors suggested that the regular thyroid function monitoring and regulation of thyroid hormone levels are important in maintaining pregnancy and promoting fetal development among thyroid cancer survivors before and during pregnancy.
引用
- Yu H, Bao P, Qiao J, et al. Adverse birth outcomes among offspring born to women diagnosed with cancer: a population-based cohort study. Am J Obstet Gynecol MFM. 2023. PMID: 37245606. doi:10.1016/j.ajogmf.2023.101036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。